Medication errors with influencing factors of polypharmacy among elderly patients using Calcium Chanel Blockers.
Background: Geriatrics refers to age-related health changes and consequently causes complications in polypharmacy, generalizing prescribing patterns. The study aimed to investigate the pervasiveness of medication inaccuracies along with drug interactions. Methodology: Out of 450 prescriptions only 210 were selected that contained Calcium Channel Blocker (CCB) and other drugs. Drug-drug interactions were articulated by Micromedex 2.0, and the harm score was determined by National Coordinating Council for Medication Error Reporting and Prevention. Results: The outcomes revealed that 645 medication errors were identified and multiple errors were present in a single prescription. The most frequent error was unstated patient's weight (98.6%) proceeds from drug-drug interactions (66.7%). According to the harm score, 36.66% of prescriptions were placed in category D, there was a statistically significant association between the drug-drug interaction and the number of prescribed drugs (p<0.0001). Conclusion: The prime solution is that the physicians should be facilitated withal trainings about drug interactions and prescription writing skills according to WHO guidelines or other recognized standards..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
International Journal of Endorsing Health Science Research - 10(2022), 2, Seite 144-149 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shagufta Nesar [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Calcium channel blocker |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
DOAJ039226026 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ039226026 | ||
003 | DE-627 | ||
005 | 20230308030103.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2022 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ039226026 | ||
035 | |a (DE-599)DOAJe26f85714cdd41ec9441922c057821d3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Shagufta Nesar |e verfasserin |4 aut | |
245 | 1 | 0 | |a Medication errors with influencing factors of polypharmacy among elderly patients using Calcium Chanel Blockers. |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: Geriatrics refers to age-related health changes and consequently causes complications in polypharmacy, generalizing prescribing patterns. The study aimed to investigate the pervasiveness of medication inaccuracies along with drug interactions. Methodology: Out of 450 prescriptions only 210 were selected that contained Calcium Channel Blocker (CCB) and other drugs. Drug-drug interactions were articulated by Micromedex 2.0, and the harm score was determined by National Coordinating Council for Medication Error Reporting and Prevention. Results: The outcomes revealed that 645 medication errors were identified and multiple errors were present in a single prescription. The most frequent error was unstated patient's weight (98.6%) proceeds from drug-drug interactions (66.7%). According to the harm score, 36.66% of prescriptions were placed in category D, there was a statistically significant association between the drug-drug interaction and the number of prescribed drugs (p<0.0001). Conclusion: The prime solution is that the physicians should be facilitated withal trainings about drug interactions and prescription writing skills according to WHO guidelines or other recognized standards. | ||
650 | 4 | |a medication error | |
650 | 4 | |a calcium channel blocker | |
650 | 4 | |a elderly | |
650 | 4 | |a hypertensive patients | |
650 | 4 | |a polypharmacy | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Muhammad Harris Shoaib |e verfasserin |4 aut | |
700 | 0 | |a Kiran Rafiq |e verfasserin |4 aut | |
700 | 0 | |a Muhammad Azhar Mughal |e verfasserin |4 aut | |
700 | 0 | |a Tayyaba Mumtaz |e verfasserin |4 aut | |
700 | 0 | |a Ishrat Younus |e verfasserin |4 aut | |
700 | 0 | |a Arfa Akram |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t International Journal of Endorsing Health Science Research |d Advance Educational Institute & Research Centre, 2020 |g 10(2022), 2, Seite 144-149 |w (DE-627)DOAJ078636442 |x 23103841 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2022 |g number:2 |g pages:144-149 |
856 | 4 | 0 | |u https://doi.org/10.29052/IJEHSR.v10.i2.2022.144-149 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/e26f85714cdd41ec9441922c057821d3 |z kostenfrei |
856 | 4 | 0 | |u https://aeirc-edu.com/ojs14/index.php/IJEHSR/article/view/838/824 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2307-3748 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2310-3841 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 10 |j 2022 |e 2 |h 144-149 |